AN ITALIAN, MULTICENTER CLINICAL TRIAL WITH ZOMETA® (ZOLEDRONIC ACID) IN BREAST CANCER PATIENTS WITH NEWLY DIAGNOSED BONE METASTASES: STUDY DESIGN, OBJECTIVES AND PATIENT POPULATION


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles